Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC) (TheraSphere)

This study has been completed.
MDS Pharma Services
Information provided by (Responsible Party):
Robert C. Martin, University of Louisville Identifier:
First received: May 16, 2008
Last updated: October 18, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):